Home › Diffuse Scleroderma › Massachusetts › Boston
Diffuse Scleroderma clinical trials in Boston, MA
5 studies for Diffuse Scleroderma are looking for participants at sites in and around Boston (within about 30 miles). Open a study to see who can join and how to contact the study team.
EncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic Sclerosis (dcSSc)
RecruitingPhase 2
- Brigham and Women's Hospital, Boston
- Boston Medical Center, Boston
A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
RecruitingPhase 1
- Boston Medical Center, Boston
Platform Clinical Study for Conquering Scleroderma
RecruitingPhase 2
- Massachusetts General Hospital, Boston
- Boston University (BU), Boston
Diffuse Cutaneous Scleroderma (DSSc) SFDI Study
RecruitingHealthy volunteers welcome
- Shapiro Outpatient Rheumatology Clinic at Boston Medical Center, Boston
A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
RecruitingPhase 1
- Brigham And Womens Hospital, Boston
Diffuse Scleroderma trials in other cities
- New York City, NY8 studies
- Chicago, IL7 studies
- Ann Arbor, MI7 studies
- Los Angeles, CA6 studies
- Durham, NC6 studies
- Houston, TX5 studies
- Baltimore, MD5 studies
- Philadelphia, PA4 studies
- Kansas City, KS4 studies
- Pittsburgh, PA4 studies
- New Orleans, LA4 studies
- Charleston, SC3 studies
Other studies in Boston
- Breast Cancer110 studies
- Non-Small Cell Lung Cancer89 studies
- Cancer (all types)86 studies
- Metastatic Cancer63 studies
- Colorectal Cancer63 studies
- Lung Cancer62 studies
- Ovarian Cancer61 studies
- Prostate Cancer61 studies
- Depression51 studies
- Endometrial Cancer50 studies
- Acute Myeloid Leukemia45 studies
- Pancreatic Cancer44 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.